Skip to main content
. 2021 Mar 31;22(7):3632. doi: 10.3390/ijms22073632

Table 1.

Over and aberrant expression of RARγ in human cancers.

Malignancy RARγ Expression Impact on Disease
Acute myeloid leukemia RARγ chimeric protein Not responsive to retinoid-based therapy
Colorectal carcinoma Overexpression Resistance to chemotherapeutics
Cholangiocarcinoma Overexpression Poor prognosis and drug resistance
Hepatocellular carcinoma Overexpression Promotes growth of xenografts
Renal cell carcinoma Overexpression May contribute to disease progression